COST-EFFECTIVENESS ANALYSIS OF SACUBITRIL/VALSARTAN IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR ELIGIBLE PATIENTS

被引：0
|
作者：
Kaddoura, R. [1 ]
Abushanab, D. [2 ]
Arabi, A. R. [3 ]
Al-Badriyeh, D. [4 ]
机构：
[1] Hamad Med Corp, Heart Hosp, Pharm Dept, Doha, Qatar
[2] Hamad Med Corp, Doha, Qatar
[3] Hamad Med Corp, Heart Hosp, Cardiol Dept, Doha, Qatar
[4] Qatar Univ, Qatar Univ Hlth, Coll Pharm, Doha, Qatar
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE432
引用
收藏
页码：S419 / S419
页数：1
相关论文
共 50 条
  • [1] Sacubitril/valsartan or an implantable cardioverter-defibrillator in heart failure with reduced ejection fraction patients: a cost-effectiveness analysis
    Zaca, Valerio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (10) : 597 - 605
  • [2] Cost-effectiveness of implantable cardioverter-defibrillator
    不详
    HEART RHYTHM, 2006, 3 (01) : 126 - 126
  • [3] COST-EFFECTIVENESS OF THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    DELISSOVOY, G
    GUARNIERI, T
    PROGRESS IN CARDIOVASCULAR DISEASES, 1993, 36 (03) : 209 - 213
  • [4] Cost-Effectiveness Analysis of Sacubitril/Valsartan for Reducing the Use of Implantable Cardioverter-Defibrillator (ICD) and the Risk of Death in ICD-Eligible Heart Failure Patients with Reduced Ejection Fraction
    Kaddoura, Rasha
    Abushanab, Dina
    Arabi, Abdul Rahman
    Alyafei, Sumaya Alsaadi
    Al-Badriyeh, Daoud
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (12)
  • [5] Cost-Effectiveness Analysis of Sacubitril/Valsartan for Reducing the Use of Implantable Cardioverter-Defibrillator (ICD) and the Risk of Death in ICD-Eligible Heart Failure Patients With Reduced Ejection Fraction
    Kumar, Neeraj
    Rauf, Sameer Abdul
    Rajendar, Riya
    Arbab, Shahdil
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (01)
  • [6] EVALUATING AND IMPROVING THE COST-EFFECTIVENESS OF THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    KUPERSMITH, J
    HOGAN, A
    GUERRERO, P
    GARDINER, J
    MELLITS, ED
    BAUMGARDNER, R
    ROVNER, D
    HOLMESROVNER, M
    MCLANE, A
    LEVINE, J
    SAKSENA, S
    GRIFFITH, L
    AMERICAN HEART JOURNAL, 1995, 130 (03) : 507 - 515
  • [7] IMPROVING COST-EFFECTIVENESS OF THE TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    GUERRERO, P
    HOGAN, A
    GARDINER, J
    MELLITS, ED
    BAUMGARDNER, RA
    ROVNER, D
    HOLMESROVNER, M
    MCLANE, A
    LEVINE, J
    SAKSENA, S
    GRIFFITH, L
    KUPERSMITH, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A206 - A206
  • [8] Cost-effectiveness of the implantable cardioverter-defibrillator - Results from the Canadian Implantable Defibrillator Study (CIDS)
    O'Brien, BJ
    Connolly, SJ
    Goeree, R
    Blackhouse, G
    Willan, A
    Yee, R
    Roberts, RS
    Gent, M
    CIRCULATION, 2001, 103 (10) : 1416 - 1421
  • [9] Potential cost-effectiveness of wearable cardioverter-defibrillator for patients with implantable cardioverter-defibrillator explant in a high-income city of China
    Jiang, Xinchan
    Ming, Wai-Kit
    You, Joyce H. S.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2019, 30 (11) : 2387 - 2396
  • [10] Cost-effectiveness of the implantable cardioverter defibrillator?
    Hlatky, MA
    Bigger, T
    LANCET, 2001, 357 (9271): : 1817 - 1818
12345